0001375151-19-000131.txt : 20191127 0001375151-19-000131.hdr.sgml : 20191127 20191127161425 ACCESSION NUMBER: 0001375151-19-000131 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191125 FILED AS OF DATE: 20191127 DATE AS OF CHANGE: 20191127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FARR STEPHEN J CENTRAL INDEX KEY: 0001247666 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34962 FILM NUMBER: 191258020 MAIL ADDRESS: STREET 1: SFARR@ZOGENIX.COM CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 500 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 550-8300 MAIL ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 500 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 4 1 wf-form4_157488924668533.xml FORM 4 X0306 4 2019-11-25 0 0001375151 ZOGENIX, INC. ZGNX 0001247666 FARR STEPHEN J C/O ZOGENIX, INC. 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608 1 1 0 0 President and CEO Common Stock 2019-11-25 4 M 0 34225 10.35 A 90752 D Common Stock 2019-11-25 4 S 0 34225 50 D 56527 D Stock Option (Right to Buy) 10.35 2019-11-25 4 M 0 34225 0 D 2026-03-13 Common Stock 34225.0 129987 D The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. The option was granted on March 14, 2016 and vests in a series of forty-eight (48) successive, equal monthly installments beginning on April 14, 2016, subject to the reporting person's continuous service to the Company on each vesting date. /s/ Thomas Doyle, Attorney-in-fact for Stephen Farr 2019-11-27